Condition
Leukemia, Myelomonocytic, Chronic clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Leukemia, Myelomonocytic, Chronic clinical trials that are recruiting, at sites in 3 countries (most in Canada (1), United Kingdom (1), United States (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Pacritinib versus Hydroxyurea for advanced proliferative chronic myelomonocytic leukemia
This trial tests whether pacritinib works better than hydroxyurea for adults with advanced proliferative chronic myelomonocytic leukemia.
-
Registry for patients with myeloproliferative neoplasms
This study is creating a database to gather information from people with myeloproliferative neoplasms to help improve treatments and outcomes for these rare blood cancers.
Related topics
Quick answers
How many Leukemia, Myelomonocytic, Chronic clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Canada (1 trial), United Kingdom (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.